Inside Innovation

To address ongoing Covid-19 infections in low-income countries, The Bill & Melinda Gates Foundation is donating $120 million to increase access to molnupiravir, an antiviral

While many companies across the U.S. shifted to remote work in 2020, Seattle became the top market for tech firms looking for large office spaces.

During Dr. Leslie Alexandre’s five years as CEO of Life Science Washington, the region’s life science industry has experienced a massive rise in IPOs and

Life Science Washington’s economic impact reports reveals a 23.5% rise in employment in the field from 2015-2019, reflecting tremendous growth in the region as a

Immusoft, a Seattle-based biotech has announced a partnership with Takeda to create treatments for rare neurometabolic conditions. As a result of the $900 million deal,

Local Seattleite Trevor Bedford has been selected as a recipient of the John D. and Catherine T. MacArthur Foundation’s annual MacArthur Fellowship, which awards funding

As previously announced, Dr. Leslie Alexandre will be stepping down from her role as President and CEO of Life Science Washington at the end of

Absci announced a new partnership with EQRx, a Cambridge, Massachusetts pharmaceutical company focused on developing lower-cost medicines. The two companies plan to jointly engineer and

LPC West and Invesco Real Estate have purchased a nine-story building in South Lake Union, known as Cascadian, for $164.5 million with the intention of

The Howard Hughes Medical Institute (HHMI) has recognized 33 scientists across the U.S. for outstanding scientific research, rewarding them with a total of $300 million.

In September, several life sciences companies attended the East West Life Science Summit hosted by Life Science Washington, discussing the many benefits to starting their

Adaptive Biotechnologies, a Seattle-based biotech company founded to search for cures to cancer, is now expanding its mission to develop solutions to fight COVID-19 by